Economic models in type 2 diabetes

A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment

(2010) Jean-Eric Tarride et al.   PHARMACOECONOMICS

Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy

(2008) B. Schwarz et al.   DIABETES OBESITY & METABOLISM

Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications

(2008) J. Chen et al.   DIABETES OBESITY & METABOLISM

The economic analyses of the UK prospective diabetes study

(2008) A. M. Gray et al.   DIABETIC MEDICINE

Cost-Utility Analysis of Intensive Blood Glucose Control with Metformin versus Usual Care in Overweight Type 2 Diabetes Mellitus Patients in Beijing, P.R. China

(2008) Xuanqian Xie et al.   VALUE IN HEALTH

Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand

(2008) Suphachai Chirakup et al.   VALUE IN HEALTH

Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus

(2007) Michael E. Minshall et al.   VALUE IN HEALTH